Pipemidic acid trihydrate

Suppliers

Names

[ CAS No. ]:
72571-82-5

[ Name ]:
Pipemidic acid trihydrate

[Synonym ]:
Pipemidic acid hydrate (JP16)
8-Ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acid 3H2-O
Pipemidic acid trihydrate
Pyrido(2,3-d)pyrimidine-6-carboxylic acid,5,8-dihydro-8-ethyl-5-oxo-2-(1-piperazinyl)-,trihydrate
C14H17N5O3.3H2O
Karunomazin (TN)

Chemical & Physical Properties

[ Density]:
1.41g/mLat 25°C (lit.)

[ Boiling Point ]:
534.9ºC at 760 mmHg

[ Melting Point ]:
253-255°

[ Molecular Formula ]:
C14H17N5O3

[ Molecular Weight ]:
303.31600

[ Flash Point ]:
277.3ºC

[ Exact Mass ]:
303.13300

[ PSA ]:
100.35000

[ LogP ]:
0.31300

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
Very slightly soluble in water and in methylene chloride, practically insoluble in ethanol (96 per cent). It dissolves in dilute solutions of acids and of alkali hydroxides.

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UV1153850
CHEMICAL NAME :
Pyrido(2,3-d)pyrimidine-6-carboxylic acid, 5,8-dihydro-8-ethyl-5-oxo-2-(1-piperazinyl)-, trihydrate
CAS REGISTRY NUMBER :
72571-82-5
LAST UPDATED :
199609
DATA ITEMS CITED :
12
MOLECULAR FORMULA :
C14-H17-N5-O3.3H2-O
MOLECULAR WEIGHT :
357.42
WISWESSER LINE NOTATION :
T66 BN DN GV JNJ HVQ J2 C- DT6M DNTJ &QH 3

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,634,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1635 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,634,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
575 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,634,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,634,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1274 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,634,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
610 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,634,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,634,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,634,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 10,232,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
1213 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 10,232,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
529 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 10,232,1979 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
200 mg/kg/2D-I
TOXIC EFFECTS :
Behavioral - ataxia Musculoskeletal - joints
REFERENCE :
85ISAN "Modern Pharmaceuticals of Japan, VI," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Association 1981 Volume(issue)/page/year: -,9-94,1981

Safety Information

[ RTECS ]:
UV1153850

[ HS Code ]:
2933990090

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%


Related Compounds

  • Pipemidic acid
  • pipemidic acid
  • nitric acid,trihydrate
  • phosphoric acid,trihydrate
  • sulfuric acid,trihydrate
  • Sulfuric acid trihydrate
  • 2-[1-(azetidin-3-yl)-1H-1,2,3-triazol-5-yl]-5-methylpyrimidine
  • 1-(azetidin-3-yl)-5-(1-ethyl-1H-1,2,4-triazol-5-yl)-1H-1,2,3-triazole
  • 3-[1-(pyrrolidin-3-yl)-1H-1,2,3-triazol-5-yl]pyridazine
  • 1-Aminocyclohexane-1-carboximidamidedihydrochloride
  • 5-(1-methyl-1H-imidazol-5-yl)-1-(pyrrolidin-3-yl)-1H-1,2,3-triazole
  • 2-[1-(pyrrolidin-3-yl)-1H-1,2,3-triazol-5-yl]pyrimidine
  • 3-[5-(1,3-thiazol-5-yl)-1H-1,2,3-triazol-1-yl]piperidine
  • tert-butyl (3R)-3-[(butylamino)methyl]piperidine-1-carboxylate
  • tert-butyl (3R)-3-{[(2-methylpropyl)amino]methyl}piperidine-1-carboxylate
  • tert-butyl (3R)-3-{[(cyclopropylmethyl)amino]methyl}piperidine-1-carboxylate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.